Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
about
Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435Protective role of osteopontin in endodontic infection.
P2860
Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@en
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@nl
type
label
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@en
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@nl
prefLabel
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@en
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@nl
P2093
P2860
P1476
Osteopontin antisense deoxyoli ...... by mouse osteoclasts in vitro.
@en
P2093
N Tani-Ishii
P2860
P304
P356
10.1111/J.1600-0765.1997.TB00563.X
P577
1997-08-01T00:00:00Z